CAR19-BCMA Dual-target CAR-T

· Institute of Hematology & Blood Diseases Hospital, China

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR19-BCMA Dual-target CAR-T, covering 2025-11-25 to 2025-11-25. Get the full timeline:

Most recent: Clinical Trial Update: CAR19-BCMA Dual-target CAR-T in the Treatment of Relapsed / Refractory Multiple Myeloma [EARLY_Phase 1]